Characterization of non pigmented B16 melanoma cell-derived cytotoxic factors

Effects of in vivo freezing and mannitol in intestinal ischaemia-reperfusion injury

PURPOSE

The main purpose of this study was to investigate whether in vivo freezing and mannitol administration can protect the small intestine against ischaemia-reperfusion (I-R) injury.

METHODS

Fifty male Sprague-Dawley rats (200-225 g) were divided into 5 groups each containing 10 rats; group SO, sham operation group; group I, mesenteric ischaemia group; group R, ischaemia-reperfusion (I-R); group FR, I-R plus in vivo freezing; group MR, I-R plus mannitol treatment. Intestinal ischaemia for 30 min and reperfusion for 60 min were applied. Ileum specimens were obtained to determine the tissue levels of malondialdehyde (MDA) and histological changes.

RESULTS

The mucosal injury scores of group R were significantly higher than those of the group I (P<0.0001). The mucosal injury scores in the groups FR and MR were significantly lower than the group R (P<0.0001 and P<0.0001, respectively). In the group FR, mucosal injury scores were not significantly different from those of group I (P=0.123). However, mucosal injury scores of group MR were significantly less when compared to those of group I (P=0.01). Mean MDA levels of group R were significantly higher than those of the group I (P<0.0001). Mean MDA levels of groups FR and MR were significantly lower than those of group R (P<0.0001 and P<0.0001, respectively). In addition, MDA levels of group FR were significantly higher than those of group MR (P<0.0001).

CONCLUSION

In conclusion, these observations suggest that the in vivo freezing of SMA and the pre-treatment with mannitol before reperfusion period may be useful in preventing intestinal reperfusion injury.

Suppression of macrophage function by substances with a molecular weight lower than 3000 Da in B16 melanoma-conditioned medium

In the present study, B16 melanoma cells were found to produce inhibitory and cytotoxic substances with a molecular weight lower than 3000 Da against macrophages in a conditioned medium. The B16 melanoma-conditioned medium suppressed nitric oxide (NO) production only by mouse peritoneal macrophages and the mouse macrophage-like cell line, RAW264.7 cells, but not by rat peritoneal macrophages. In addition, it showed cytotoxicity against mouse peritoneal macrophages and mouse macrophage-like cell lines, RAW264.7 and J774A.1 cells, but not against rat cells (peritoneal macrophages, 3Y1, hepatocytes), human cells (HeLa, KB, MCF-7), or mouse 3T3-L1 cells. The inhibitory activity of NO production was not affected by trypsin treatment or arginine supplementation, but it was abolished by heat treatment at 95 degrees C for 3 min. On the other hand, the cytotoxicity was not influenced by these treatments. Inducible NO synthase induction following lipopolysaccharide stimulation was reduced by treatment of mouse peritoneal macrophages with B16 melanoma-conditioned medium. These results suggest that metastatic B16 melanoma cells produce two distinct substances: to suppress NO production by macrophages and to kill macrophages and macrophage-like cell lines. We propose that these activities may help metastatic B16 melanoma cells to escape a host immunosurveillance system and to metastasize to target organs.